Selenium prevents diabetes-induced alterations in [Zn2+] i and metallothionein level of rat heart via restoration of cell redox cycle

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 3, 2006, Pages

  Ayaz, Murat ^a   Turan, Belma ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Intracellular calcium; Intracellular zinc; Oxidant stress; Type 1 diabetes

Indexed keywords

CALCIUM ION; CHELATING AGENT; FURA 2; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; METALLOTHIONEIN; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; NITRIC OXIDE; SELENIUM; SODIUM SELENITE; SUPEROXIDE DISMUTASE; ZINC ION; CALCIUM; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL CYCLE; CONTROLLED STUDY; CYTOFLUOROMETRY; DIABETES MELLITUS; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; EXCITATION CONTRACTION COUPLING; FEMALE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; INTRACELLULAR SPACE; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL DIABETES MELLITUS; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; METABOLISM; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; CALCIUM; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SELENIUM; STREPTOZOCIN; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; ZINC;

EID: 33645740498     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00754.2005     Document Type: Article

References (64)

1. Atar D, Backx PH, Appel MM, Gao WD, and Marban E. Excitation- transcription coupling mediated by zinc influx through voltage-dependent calcium channels. J Biol Chem 270: 2473-2477, 1995.
2. Ayaz M, Can B, Ozdemir S, and Turan B. Protective effect of selenium treatment on diabetes-induced myocardial structural alterations. Biol Trace Elem Res 89: 215-226, 2002.
3. Ayaz M, Ozdemir S, Ugur M, Vassort G, and Turan B. Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys 426: 83-90, 2004.
4. Ayaz M, Ozdemir S, Yaras N, Vassort G, and Turan B. Selenium-induced alterations in ionic currents of rat cardiomyocytes. Biochem Biophys Res Commun 327: 163-173, 2005.
5. Banman JW, Liu J, Liu YP, and Klaassen CD. Increase in metallothionein produced by chemicals that induce oxidative stress. Toxicol Appl Pharmacol 110: 347-354, 1991.
6. Beckman JA, Goldfine AB, Gordon MB, and Creager MA. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 103: 1618-1623, 2001.
7. Berg EA, Wu JY, Campbell L, Kagey M, and Stapleton SR. Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats. Biochimie 77: 919-924, 1995.
8. + channels. Neuron 41: 351-365, 2004.
9. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
10. Cai L, Wang j Li Y, Wang L, Zhou Z, and Kang YJ. Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes 54: 1829-1837, 2005.
11. Ceriello A, Dello Russo P, Amstad P, and Cerutti P. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes 45: 471-477, 1996.
12. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 26: 1589-1596, 2003.
13. Cheng XY, Chen KY, Zhang XH, and Zhu PH. Effect of zinc ions on caffeine-induced contracture in vascular smooth muscle and skeletal muscle of rat. Cell Physiol Biochem 12: 119-126, 2002.
14. 2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283: H1398-H1408, 2002.
15. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, and Yorek MA. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50: 1927-1937, 2001.
16. Cousins RJ. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev 65: 238-309, 1985.
17. Da Ros R, Assaloni R, and Ceriello A. Antioxidant therapy in diabetic complications: what is new? Curr Vasc Pharmacol 2: 335-341, 2004.
18. Dhalla NS, Liu X, Panagia V, and Takeda N. Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 40: 239-247, 1998.
19. Dineley KE, Richards LL, Votyakova TV, and Reynolds IJ. Zinc causes loss of membrane potential and elevates reactive oxygen species in rat brain mitochondria. Mitochondrion 5: 55-65, 2005.
20. Ezaki O. The insulin-like effects of selenate in rat adipocytes. J Biol Chem 265: 1124-1130, 1990.
21. Fang ZY, Prins JB, and Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25: 543-567, 2004.
22. Foyer CH, Theodoulou FL, and Delrot S. The functions of inter- and intra- cellular glutathione transport systems in plants. Trends Plant Sci 6: 486-492, 2001.
23. Fructaci A, Kajstura J, Chimenti C, Jakoniuk I, Nadal-Ginard B, Maseri A, Nadal-Ginard B, and Anversa P. Myocardial cell death in human diabetes. Circ Res 87: 1123-1132, 2000.
24. Ghosh R, Mukherjee B, and Chatterjee M. A novel effect of selenium on streptozotocin-induced diabetic mice. Diabetes Res 25: 165-171, 1994.
25. Haase H and Maret W. A differential assay for the reduced and oxidized states of metallothionein and thionein. Anal Biochem 333: 19-26, 2004.
26. Haase H and Maret W. Intracellular zinc fluctuations modulate protein tyrosine phosphate activity in insulin/insulin-like growth factor-1 signaling. Exp Cell Res 291: 289-298, 2003.
27. Hayat SA, Patel B, Khattar RS, and Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 107: 539-557, 2004.
28. Hei YJ, Farahbakhshian S, Chen X, Battell ML, and McNeill J. Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes. Mol Cell Biochem 178: 367-375, 1998.
29. 2+ and regulates ion transport. Proc Natl Acad Sci USA 98: 11749-11754, 2001.
30. 2+ handling in streptozotocin-induced diabetic rat myocardium. Am J Physiol Heart Circ Physiol 277: H2185-H2194, 1999.
31. Jacob C, Maret W, and Vallee BL. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc Natl Acad Sci USA 95: 3489-3494, 1998.
32. Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, Limana F, Nadal-Ginard B, Nadal-Ginard B, and Anversa P. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50: 1414-1424, 2001.
33. Kang YJ. The antioxidant function of metallothionein in the heart function. Proc Soc Exp Biol Med 222: 263-273, 1999.
34. Keppler D. Export pumps for glutathine S-conjugates. Free Radic Biol Med 27: 985-991, 1999.
35. 2+-induced cell death. Neuroreport 14: 187-190, 2003.
36. Korichneva I, Hoyos B, Chua R, Levi E, and Hammmerling U. Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen. J Biol Chem 277: 44327-44331, 2002.
37. Li S, Li X, and Rozanski GJ. Regulation of glutathione in cardiac myocytes. J Mol Cell Cardiol 35: 1145-1152, 2003.
38. Liang Q, Carlson EC, Donthia RV, Kralik PM, Shen X, and Epstein PN. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51: 174-181, 2002.
39. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
40. Malaiyandi LM, Dineley KE, and Reynolds IJ. Divergent consequences arise from metallothionein overexpression in astrocytes: zinc buffering and oxidant-induced zinc release. Glia 45: 346-353, 2004.
41. Maret W. Crosstalk of the group IIa and IIb metals calcium and zinc in cellular signaling. Proc Natl Acad Sci USA 98: 12325-12327, 2001.
42. Maret W. Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc. Neurochem Int 27: 111-117, 1995.
43. Marfella R, Verrazzo G, Acampora R, La Marca C, Giunta R, Lucarelli C, Paolisso G, Ceriello A, and Giugliano D. Glutathione reserves systemic hemodynamic changes by acute hyperglycemia in healthy subjects. Am J Physiol Endocrinol Metab 268: E1167-E1173, 1995.
44. Mukherjee B, Anbszhagan S, Roy A, Ghosh R, and Chatterjee M. Novel implications of the potential role of selenium on antioxidant status in streptozotocin-induced diabetic mice. Biomed Pharmacother 52: 89-95, 1998.
45. i by copper and zinc in rat cardiomyocytes. J Cardiovasc Pharmacol Ther 3: 291-298, 1998.
46. Nasu T. Zinc ions block the intracellular calcium release induced by caffeine in guinea-pig taenia caeci. Experientia 51: 113-116, 1995.
47. Nebot C, Moutet M, Huet P, Xu JZ, Yadan JC, and Chaudiere J. Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem 214: 442-451, 1993.
48. 2+ concentration and pH of diabetic rat myocytes during metabolic inhibition. J Mol Cell Cardiol 24: 435-446, 1992.
49. Pacher P, Liaudet L, Soriano FG, Mabley JG, and Szabo E. The role of poly(ADP-Ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51: 514-521, 2002.
50. Pacher P, Obrosova IG, Mabley JG, and Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 12: 267-275, 2005.
51. Paglia DE and Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169, 1967.
52. 2+ signaling in diabetic patients are due to increased formation of superoxide anions and reduced nitric oxide production. Diabetologia 42: 167-176, 1999.
53. Scheuhammer AM and Cherian MG. Quantification of metallothioneins by a silver saturation method. Toxicol Appl Pharmacol 82: 417-425, 1986.
54. Stapleton SR, Garlock G, Foellmi-Adam L, and Kletzien RF. Selenium: potent stimulator of tyrosyl phosphorylation and activator of MAP kinase. Biochim Biophys Acta 1355: 259-269, 1997.
55. Szabo C, Zanchi A, Komjati K, Pacher P, Krolewski AS, Quist WC, LoGerfo FW, Horton ES, and Veves A. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 106: 2680-2686, 2002.
56. Tatsumi T and Fliss H. Hypochlorous acid mobilizes intracellular zinc in isolated rat heart myocytes. J Mol Cell Cardiol 26: 471-479, 1994.
57. 2+ concentration in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 272: H2095-H2106, 1997.
58. Ulusu NN and Turan B. Beneficial effects of selenium on some enzymes of diabetic rat heart. Biol Trace Elem Res 103: 207-215, 2005.
59. Vega MT, Villalobos C, Garrido B, Gandia L, Bulbena O, Garcia-Sancho J, Garcia AG, and Artalejo AR. Permeation by zinc of bovine chromaffin cell calcium channels: relevance to secretion. Pflügers Arch 429: 231-239, 1994.
60. 2+ in heavy metal cytotoxicity. Comp Biochem Physiol 100C: 81-84, 1991.
61. 2+ ions. Cell Physiol Biochem 11: 83-92, 2001.
62. + channels in diabetic rat ventricular myocytes by insulin and glutathione. Cardiovasc Res 53: 80-88, 2002.
63. Ye G, Metreveli NS, Ren J, and Epstein PN. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52: 777-783, 2003.
64. Yu JZ, Rodrigues B, and McNeill JH. Intracellular calcium levels are unchanged in the diabetic heart. Cardiovasc Res 34: 91-98, 1997.